I am pleased to welcome your inquiry into our residency training program in the Department of Radiation Oncology here at Thomas Jefferson University Hospital. Our department offers a four-year fully accredited residency and plans to review candidates for the two anticipated positions for July, 2013. Our program is accredited for eight residency positions and we additionally have one clinical fellowship position.
We have been a leader in the area of organ preservation in breast, laryngeal and colorectal cancer and have always been at the forefront of evaluating new technology. Over the past decade, our group has also gained increasing prominence in developing innovative approaches to brain tumors, prostate cancer, lung cancer, and clinical trial design. We have introduced new treatment planning and delivery tools into our clinic in recent years, including a dedicated stereotactic linear accelerator, a Gamma Knife unit, intensity-modulated radiotherapy, stereotactic therapy to extracranial sites, dedicated intro-operative radiotherapy site, several innovative 3-D treatment planning systems, and a CyberKnife facility in Bensalem, PA. Over 2,000 new patients are seen each year at our main facility at Jefferson, and an additional 1,500 new patients are seen at our five other treatment sites.
The oncology program throughout Jefferson, as organized within the NCI-designated Kimmel Cancer Center, has gained wide national recognition. Our department has a number of important leadership positions within the Radiation Therapy Oncology Group and is among the leading accruers to radiation oncology-oriented clinical trials in the nation. All of our faculty are dedicated to postgraduate education and teach within the context of a multi-disciplinary approach to cancer patients and cancer research. We look forward to reviewing your completed application and meeting you in the fall.
Adam P. Dicker, MD, PhD
Professor and Chair
Department of Radiation Oncology